Business · 14/05/2021Updated: 10/17/2026 · 1 min read
FDA Clears OVIDE (Malathion) Lotion for Sale
Summary
The US Food and Drug Administration (FDA) has ruled that OVIDE (malathion) lotion, 0.5%, will not be removed from the market due to safety or efficacy concerns, allowing the agency to continue approving abbreviated new drug applications (ANDAs) for the product.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →